Hetrombopag, a Thrombopoietin Receptor Agonist, Protects Cardiomyocyte Survival from Oxidative Stress Damage as an Enhancer of Stem Cells

Nannan Zhou(Yunnan Agricultural University), Chengwei Zou(Shandong University), Yuanyuan Sun(Jinzhou Medical University), Yong Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaodong Li(Université Toulouse III - Paul Sabatier), Jianchun Wang(Capital Normal University)
Cardiovascular Drugs and Therapy
November 12, 2016
Cited by 2


Related Papers